We found that YDJC induced EMT via ERK2 activation by PP2A downregulation through ubiquitination leading to the promotion of the progression of lung cancer and CDC16 reversed this by directly interacting with YDJC leading to ubiquitination. The gene discussed is YDJC; the disease is lung cancer.